300573 Shenyang Xingqi Pharmaceutical
- 84.17
- -0.97-1.14%
About Shenyang Xingqi Pharmaceutical Company
The company is a national high-tech enterprise specializing in R&D, production and sales of ophthalmic drugs. On December 8, 2016, the company was listed on the Shenzhen Stock Exchange GEM. It won the 9th Liaoning Provincial Governor's Quality Silver Award in 2022 and the 20th National Quality Award in 2023. The company leads the high-quality development of enterprises with high-quality party building, adheres to the mission of “managing health and creating light”, implements the values of “persistence, innovation, responsibility and win-win” with the vision of “becoming a globally competitive ophthalmic drug research and manufacturing enterprise”, and actively invests in the human eye health industry. The company is a professional ophthalmic drug R&D, production and sales enterprise with leading R&D technology level and wide product line coverage in China. The company's products include drugs to slow the progression of myopia in children, drugs to treat dry eye, ophthalmic anti-infective drugs, ophthalmic antiinflammatory/anti-infective drugs, pupil dilators and ciliary muscle paralysis drugs, ophthalmic non-steroidal anti-inflammatory drugs, pupil reduction drugs, and anti-glaucoma drugs. Corporate honors include: the State Intellectual Property Office recognized as a national intellectual property model enterprise, won the “9th Governor's Quality Award Silver Award of Liaoning Province”, “Liaoning May 1st Labor Award”, “2021-2023 Pharmaceutical Industry Law-abiding and Honest Enterprise”, “Provincial Green Factory”, “14th China Listed Company Investor Relations Tianma Award”, the 20th “National Quality Award”, the 19th China Listed Company Board of Directors “Excellent Board of Directors”, “2023 Biochemical and Biological Enterprise Outstanding Brand”, won the honorary title of “2023 Biochemical and Biological Enterprise Award”, and won the honorary title of Ophthalmology Science and Technology Progress Award, “Brand Enterprise List”” The “List of Most Popular Brands in Retail Pharmacies” and the company's product Erming Sodium Hyaluronate Eye Drops won the “Most Recommended Brand by Eye Health Clerk”, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- jidong liu
- Chairman, directors, Strategy Committee Convener, Environmental, Social and Governance (ESG) Committee Convener
- --
- shaoyao zhang
- Vice Chairman, directors, Board Secretary, Deputy General Manager, Member of the Environmental, Social and Governance (ESG) Committee, Nomination Committee Members
- --
- qiang yang
- Directors, Deputy General Manager
- --
- yanan cheng
- Directors, Deputy General Manager, Chief Financial Officer, Member of the Remuneration and Assessment Committee
- --
- e gao
- directors, general manager, Member of the Environmental, Social and Governance (ESG) Committee, Strategy Committee Member
- --
- chunhua li
- Directors
- --
- xiaoyan kong
- Independent Directors, Audit Committee Member, Remuneration and Assessment Committee Convener, Nomination Committee Convener
- --
- xianmei xu
- Independent Directors, Member of the Remuneration and Assessment Committee, Audit Committee Convener, Nomination Committee Members
- --
- xiaobin dai
- Independent Directors, Strategy Committee Member, Audit Committee Member
- 106.80K
- shuo wang
- Securities Affairs Representative
- --
- xiaoyu qu
- Chairman of the Supervisory Board, Auditors
- 172.30K
- bing li
- Auditors
- 150.90K
- fei ji
- Employee Supervisors
- 164.30K
No Data
